Articles published by ImmunoGen Inc.
![](https://mms.businesswire.com/media/20231210537316/en/1964998/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20231102828508/en/840019/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20231019320151/en/1919569/22/imgnlogo.jpg)
ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2023 Operating Results
October 19, 2023
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20230928394100/en/840019/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20230717788134/en/840019/22/imgnlogo.jpg)
ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2023 Operating Results
July 17, 2023
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20230609005049/en/840019/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20230604005024/en/1810117/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20230504006111/en/840019/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20230503005305/en/840019/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20230413005128/en/840019/22/imgnlogo.jpg)
ImmunoGen Announces Conference Call to Discuss Its First Quarter 2023 Operating Results
April 13, 2023
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20230215005231/en/1713949/22/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20221104005657/en/1626742/5/Elahere_TM-Full_Logo-GYNX_Pantone.jpg)
![](https://mms.businesswire.com/media/20221020005187/en/1607787/5/imgnlogo.jpg)
ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2022 Operating Results
October 20, 2022
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20220714005101/en/1512776/5/imgnlogo.jpg)
ImmunoGen Announces Conference Call to Discuss Its Second Quarter 2022 Operating Results
July 14, 2022
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20220613005142/en/1483547/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220421005100/en/1426607/5/imgnlogo.jpg)
ImmunoGen Announces Conference Call to Discuss Its First Quarter 2022 Operating Results
April 21, 2022
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20220225005018/en/1371024/5/imgnlogo.jpg)
ImmunoGen Reports Recent Progress and 2021 Financial Results
February 25, 2022
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20220215005481/en/1359614/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220210005022/en/1353773/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220201005468/en/1345147/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20220131005121/en/1342961/5/imgnlogo.jpg)
ImmunoGen Appoints Mimi Huizinga, MD, as Senior Vice President and Head of Medical Affairs
January 31, 2022
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20220103005412/en/1317123/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211201006279/en/932412/5/imgnlogo.jpg)
ImmunoGen Announces Pricing of Upsized Public Offering of Common Stock
December 02, 2021
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20211130006063/en/931610/5/imgnlogo.jpg)
ImmunoGen Announces Proposed Public Offering of Common Stock
November 30, 2021
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20211130005310/en/931177/5/imgnlogo.jpg)
ImmunoGen Announces Positive Top-Line Results from Pivotal SORAYA Trial of Mirvetuximab Soravtansine in Ovarian Cancer
November 30, 2021
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20211117005358/en/928041/5/imgnlogo.jpg)
ImmunoGen Appoints Tracey L. McCain, Esq. to Its Board of Directors
November 17, 2021
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20211116006082/en/927756/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211116005083/en/927132/5/imgnlogo.jpg)
ImmunoGen Appoints Kristen Harrington-Smith as Senior Vice President and Chief Commercial Officer
November 16, 2021
From ImmunoGen Inc.
Via Business Wire
Tickers
IMGN
![](https://mms.businesswire.com/media/20211101006016/en/922410/5/imgnlogo.jpg)
![](https://mms.businesswire.com/media/20211029005032/en/921377/5/imgnlogo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.